BIIB: biogen.com Expected earnings per share growth for next year
Biogen Inc. is advancing neuropharmaceuticals through global partnerships and the acquisition of promising biotech startups. The forward-looking growth in net earnings per share demonstrates a fundamental development vector, where the 29.30 mark serves as a key metric. New leadership under C. Viehbacher is currently optimizing expenses and reviewing the product portfolio. Staff stabilization and the targeted hiring of immunology experts are concluding the restructuring phase.
Analytical breakdowns for Biogen Inc.
- price and consensus price forecast:
- market capitalization information:
- book capitalization information:
- company total debt and liquidity indicators:
- earnings and valuation multiples information:
BIIB - Net Financial Result|Projected Future Earnings Biogen Inc.|BIIB - Price to Earnings Ratio|Future Price to Earnings Biogen Inc.|BIIB - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Biogen|BIIB - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Biogen|BIIB - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months biogen.com|BIIB - Earnings per share increase in current year|Net earnings per share growth forecast for next year Biogen Inc.
Initial company analysis:Biogen Corp, BIIB
The new CEO of Biogen Inc. (BIIB) has successfully optimized expenses and focused resources on the launch of neurological drugs. This process is quantified via the consensus EPS n+1 forecast chart, which captures analysts' average expectations for profit growth rates for the coming year. The line's upward trend confirms market confidence in the effectiveness of management's strategy. Comparing current values with historical data allows for the timely identification of asset overheating.
Key competitors
Net earnings per share growth forecast for next year Neurocrine Biosciences Inc|Projected earnings per share growth rate for next year RGC (Regencell Corp)|Expected earnings per share growth for next year AXSM (Axsome Therapeutics)|ACAD (acadia-pharm.com) - Expected earnings per share trend next year|Earnings growth forecast for next year XENE (Xenon)|Consensus forecast of earnings per share growth for next year Viking Therapeutics Inc (VKTX)|SUPN - Net earnings per share growth forecast for next year|CPRX (Catalyst Corp) - Projected earnings per share growth rate for next year|DNLI: Earnings growth forecast for next year|Expected earnings per share growth for next year harmonybiosciences.com|Expected earnings per share growth for next year BHVN|Amylyx Pharmaceuticals Inc (AMLX) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year TRVI|Net earnings per share growth forecast for next year PRAX (Praxis Corp)|Earnings growth forecast for next year AVXL (Anavex Life Sciences)|Consensus forecast of earnings per share growth for next year ceribell.com (CBLL)|Prothena - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Alector, Inc. ALEC|ANNX: Earnings growth forecast for next year|OMER (Omeros) - Net earnings per share growth forecast for next year|Net earnings per share growth forecast for next year Neurogene Inc.|Projected earnings per share growth rate for next year ACIU (acimmune.com)|Earnings growth forecast for next year VYGR|NMRA - Expected net earnings per share growth next year|Scilex Holding Co. - Expected earnings per share growth for next year|Earnings growth forecast for next year Tevogen Bio Inc. TVGN|ACOG - Net earnings per share growth forecast for next year|Expected earnings per share trend next year CGTX (Cognition Therapeutics Inc.)|Inhibikase Therapeutics, Inc. (IKT) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Cassava Sciences Inc (SAVA)|ASRT (Assertio Holdings) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year COYA|Earnings growth forecast for next year VTGN|Consensus forecast of earnings per share growth for next year ovidrx.com|Net earnings per share growth forecast for next year Acumen Pharmaceuticals, Inc. ABOS|CervoMed, Inc. (CRVO) - Expected net earnings per share growth next year|Alterity Therapeutics Ltd - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Clene Inc. (CLNN)|PEPG: Earnings growth forecast for next year|Expected net earnings per share growth next year Jupiter Neurosciences, Inc. (JUNS)|Net earnings per share growth forecast for next year Relmada Therapeutics, Inc.|Projected earnings per share growth rate for next year ANVS (Annovis Bio Inc)|Expected earnings per share growth for next year GRCE (Grace Therapeutics, Inc.)|AIFF (Firefly Neuro) - Expected earnings per share trend next year|Earnings growth forecast for next year KLTO (Klotho Neurosciences)|Consensus forecast of earnings per share growth for next year NeuroSense Therapeutics Ltd (NRSN)|RVPH - Net earnings per share growth forecast for next year|MTVA (MetaVia Inc) - Projected earnings per share growth rate for next year|NRXS: Earnings growth forecast for next year|Expected earnings per share growth for next year Helius Medical Technologies|Expected earnings per share growth for next year PASG|Neuphoria (NEUP) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year NERV|Net earnings per share growth forecast for next year ATHA (Athira Pharma Inc)|Earnings growth forecast for next year ADXN (Addex Therapeutics, Ltd.)|Consensus forecast of earnings per share growth for next year Alzamend Neuro Inc. (ALZN)|Cyclerion - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Protagenic Therapeutics PTIX|KTTA: Earnings growth forecast for next year|CRGT (Cortigent) - Net earnings per share growth forecast for next year|Net earnings per share growth forecast for next year Avenue Therapeutics, Inc|Projected earnings per share growth rate for next year BCLI (BrainStorm Cell Therapeutics Inc.)|Earnings growth forecast for next year CARA|CHRO - Expected net earnings per share growth next year|Eliem Therapeutics Inc. - Expected earnings per share growth for next year|Earnings growth forecast for next year Intra-Cellular Therapies Inc. ITCI|LBPH - Net earnings per share growth forecast for next year|Expected earnings per share trend next year MRNS (Marinus Pharma)|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year neurobopharma.com (NRBO)|SAGE (Sage Therapeutics) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year SNPX|Earnings growth forecast for next year TRVN|Consensus forecast of earnings per share growth for next year vigilneuro.com|Net earnings per share growth forecast for next year Anew Medical WENA|cerevel.com (CERE) - Expected net earnings per share growth next year
